EBMT 2019 | The TRANSCEND CLL-004 study: JCAR017

Tanya Siddiqi

Tanya Siddiqi, MD, from the City of Hope National Medical Center, Duarte, CA, provides updates from the Phase I TRANSCEND CLL-004 study (NCT03331198) for relapsed/refractory chronic lymphocytic leukemia (CLL). Dr Siddiqi was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video  
Similar topics